本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Blueprint Medicines Corporation

129.46
0.0000
成交量:- -
成交额:3.85亿
市值:83.80亿
市盈率:-52.77
高:129.46
开:129.46
低:129.46
收:129.46
52周最高:129.65
52周最低:73.04
股本:6,473.36万
流通股本:6,014.42万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.4532
每股收益(LYR):-1.0673
净资产收益率:-47.71%
总资产收益率:-9.75%
市净率:24.49
市盈率(LYR):-121.29

数据加载中...

2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/18

重要事件披露

Form 8-K - Current report
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities